[1]INAGAKI Y, TANG W, MAKUUCHI M, et al.Clinical and molecular insights into the hepatocellular carcinoma tumour marker des-γ-carboxyprothrombin[J].Liver Int, 2011, 31 (1) :22-35.
|
[2]KIM SH, MOON DB, KIM WJ, et al.Preoperative prognostic values ofα-fetoprotein (AFP) and protein induced by vitamin K absence or antagonist-II (PIVKA-II) in patients with hepatocellular carcinoma for living donor liver transplantation[J].Hepatobiliary Surg Nutr, 2016, 5 (6) :461-469.
|
[3]CUI SX, YU XF, QU XJ.Roles and signaling pathways of des-γ-carboxyprothrombin in the progression of hepatocellular carcinoma[J].Cancer Invest, 2016, 34 (9) :459-464.
|
[4]WANG H, LI JJ, MA HX, et al.Diagnostic value of serum AFPcombined with AFP-L3 in hepatocellular carcinoma:a Meta-analysis[J].Anhui Med J, 2016, 37 (10) :1211-1214. (in Chinese) 王浩, 李家军, 马怀幸, 等.甲胎蛋白联合甲胎蛋白异质体L3诊断原发性肝癌的Meta分析[J].安徽医学, 2016, 37 (10) :1211-1214.
|
[5]WANG CY.Clinical significance of serum ferritin measurement in patients with liver cancer[J].Chin J Clin Ration Drug Use, 2015, 8 (18) :69-70. (in Chinese) 王彩艳.肝癌患者血清铁含量检测的临床意义[J].临床合理用药杂志, 2015, 8 (18) :69-70.
|
[6]Ministry of Health of the People's Republic of China.Diagnosis, management, and treatment of hepatocellular carcinoma (V2011) [J].J Clin Hepatol, 2011, 27 (11) :1141-1159. (in Chinese) 中华人民共和国卫生部.原发性肝癌诊疗规范 (2011年版) [J].临床肝胆病杂志, 2011, 27 (11) :1141-1159.
|
[7] Chinese Society of Hepatology and Chinese Society of Infectious Diseases Chinese, Medical Association.The guideline of prevention and treatment for chronic hepatitis B:a 2015 update[J].J Clin Hepatol, 2015, 31 (12) :1941-1960. (in Chinese) 中华医学肝病学分会.慢性乙型肝炎防治指南 (2015年更新版) [J].临床肝胆病杂志, 2015, 31 (12) :1941-1960.
|
[8]KIM Y, PARK YH, HWANG S, et al.Diagnostic role of blood tumor markers in predicting hepatocellular carcinoma in liver cirrhosis patients undergoing liver transplantation[J].Ann Transplant, 2016, 21 (15) :660-667.
|
[9]SONG P, TANG Q, FENG X, et al.Biomarkers:evaluation of clinical utility in surveillance and early diagnosis for hepatocellular carcinoma[J].Scand J Clin Lab Invest Suppl, 2016, 245 (10) :70-76.
|
[10]JI J, WANG H, LI Y, et al.Diagnostic evaluation of des-γ-carboxyprothrombin versusα-fetoprotein for hepatitis B virus-related hepatocellular carcinoma in China:a large-scale, multicenter study[J].PLo S One, 2016, 11 (4) :e153227.
|
[11]NANASHIMA A, ABO T, TAURA N, et al.NX-PVKA levels before and after hepatectomy of hepatocellular carcinoma as predictors of patient survival:a preliminary evaluation of an improved assay for PIVKA-II[J].Anticancer Res, 2013, 33 (6) :2689-2697.
|
[12]VIGGIANI V, PALOMBI S, GENNARINI G, et al.Protein induced by vitamin K absence or antagonist-II (PIVKA-II) specifically increased in Italian hepatocellular carcinoma patients[J].Scand J Gastroenterol, 2016, 51 (10) :1257-1262.
|
[13]SULTANIK P, GINGUARY A, VANDAME J, et al.Diagnostic accuracy of des-gamma-carboxy prothrombin for hepatocellular carcinoma in a French cohort using the Lumipulse G600 analyzer[J].J Viral Hepat, 2017, 24 (1) :80-85.
|
[14]OYAMA K, KODA M, SUGIHARA T, et al.Rapid and earlyα-fetoprotein and des-γ-carboxy prothrombin responses to initial arterial infusion chemotherapy predict treatment outcomes of advanced hepatocellular carcinoma[J].Mol Clin Oncol, 2015, 3 (3) :655-662.
|
[15]OGASAWARA N, TAKAHASHI E, MATSUMOTO T, et al.Prolonged survival in a case of chemotherapy-sensitive gastric cancer that produced alpha-fetoprotein and protein induced by vitamin K antagonist-II[J].Case Rep Gastroenterol, 2015, 9 (1) :113-119.
|
[16]LIU H, ZHAN DA, LUO HX, et al.Predictive value of alpha fetal protein on prognosis of patients with severe hepatitis B[J].Int JVirol, 2016, 23 (3) :181-183. (in Chinese) 刘华, 詹东昂, 罗红霞, 等.甲胎蛋白对重型乙型肝炎患者生存状况的预测效果[J].国际病毒学杂志, 2016, 23 (3) :181-183.
|
[17]UEDA N, SHIAHA H, FUJIKAWA T, et al.Exon 2 deletion splice variant of gamma-glutamyl carboxylase causes des-gamma-carboxy prothrombin production in hepatocellular carcinoma cell lines[J].Mol Oncol, 2008, 2 (3) :241-249.
|
[18]QUAN XL, HU YL, DONG AL.The relationship between the indicators of iron metabolism and hepatic injury in patients with liver diseases[J].Beijing Med J, 2012, 34 (3) :169-173. (in Chinese) 全香兰, 胡玉琳, 董爱莲.肝病患者血清铁代谢指标与肝损伤关系的探讨[J].北京医学, 2012, 34 (3) :169-173.
|
[19]KELL DB, PRETORIUS E.Serum ferritin is an important inflammatory disease marker, as it is mainly a leakage product from damaged cells[J].Metallomics, 2014, 6 (4) :748-773.
|
[20]CUI C, NIU GP.Multi-tumor markers combined detection in diagnosis of primary hepatocellular caicinoma[J].Mod Oncol, 2015, 23 (9) :1262-1265. (in Chinese) 崔灿, 牛国平.肿瘤标记物联合检测对原发性肝癌的诊断价值[J].现代肿瘤医学, 2015, 23 (9) :1262-1265.
|
[21]XIA HL, FENG ZW, HAO WM.Application of combined measurement of three indices in early diagnosis of primary liver cancer[J].Int J Lab Med, 2016, 37 (17) :2463-2465. (in Chinese) 夏宏林, 冯忠伟, 郝维敏.3项指标联合检测在原发性肝癌早期诊断中的应用[J].国际检验医学杂志, 2016, 37 (17) :2463-2465.
|